Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin.

Ishikawa C, Ozaki H, Nakajima T, Ishii T, Kanai S, Anjo S, Shirai K, Inoue I.

J Hum Genet. 2004;49(10):582-5. Epub 2004 Sep 9.

PMID:
15365880
2.

Cerivastatin, genetic variants, and the risk of rhabdomyolysis.

Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, Taylor KD, Rotter JI, Jaquish CE, Kwok PY, Tracy RP, Psaty BM.

Pharmacogenet Genomics. 2011 May;21(5):280-8. doi: 10.1097/FPC.0b013e328343dd7d.

3.

Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis.

Kaspera R, Naraharisetti SB, Tamraz B, Sahele T, Cheesman MJ, Kwok PY, Marciante K, Heckbert SR, Psaty BM, Totah RA.

Pharmacogenet Genomics. 2010 Oct;20(10):619-29. doi: 10.1097/FPC.0b013e32833ecace.

4.

Cerivastatin-induced rhabdomyolysis: 11 case reports.

Ravnan SL, Locke C, Yee WP, Haase K.

Pharmacotherapy. 2002 Apr;22(4):533-7. Review.

PMID:
11939690
5.

Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.

Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ.

Drug Metab Dispos. 2002 Dec;30(12):1352-6.

6.

Rhabdomyolysis associated with cerivastatin: six cases within 3 months at one hospital.

Lucas RA, Weathersby BB, Rocco VK, Pepper JM, Butler KL.

Pharmacotherapy. 2002 Jun;22(6):771-4.

PMID:
12066968
7.

[Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].

Huić M, Anić B, Cikes N, Bosnić D, Sentić M, Markeljević J, Mayer M, Pazanin L.

Lijec Vjesn. 2002 Mar-Apr;124(3-4):73-6. Croatian.

PMID:
18956824
8.

[Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].

Sparing R, Sellhaus B, Noth J, Block F.

Nervenarzt. 2003 Feb;74(2):167-71. German.

PMID:
12596018
9.

[Cerivastatin and acute kidney failure caused by rhabdomyolysis].

Bravo JJ, Novoa D, Romero R, Sánchez-Guisande D.

Nefrologia. 2001 Sep-Oct;21(5):509. Spanish. No abstract available.

10.

Another report of acute rhabdomyolysis following cerivastatin monotherapy.

Milionis HJ, Tsapoga TG, Elisaf MS.

Arch Intern Med. 2001 Nov 26;161(21):2629-30. No abstract available.

PMID:
11718615
11.

The cerivastatin withdrawal crisis: a "post-mortem" analysis.

Maggini M, Raschetti R, Traversa G, Bianchi C, Caffari B, Da Cas R, Panei P.

Health Policy. 2004 Aug;69(2):151-7.

PMID:
15212862
12.

Acute rhabdomyolysis associated with cerivastatin therapy.

Garcia-Valdecasas-Campelo E, Gonzalez-Reimers E, Lopez-Lirola A, Rodriguez-Rodriguez E, Santolaria-Fernandez F.

Arch Intern Med. 2001 Mar 26;161(6):893. No abstract available.

PMID:
11268236
13.

OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis.

Tamraz B, Fukushima H, Wolfe AR, Kaspera R, Totah RA, Floyd JS, Ma B, Chu C, Marciante KD, Heckbert SR, Psaty BM, Kroetz DL, Kwok PY.

Pharmacogenet Genomics. 2013 Jul;23(7):355-64. doi: 10.1097/FPC.0b013e3283620c3b.

14.

[Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].

Sirvent AE, Cabezuelo JB, Enríquez R, Amorós F, González C, Reyes A.

Nefrologia. 2001 Sep-Oct;21(5):497-500. Review. Spanish.

15.

[Rhabdomyolysis complicated with acute renal insufficiency in a patient treated with gemfibrozil and cerivastatin].

Vascónez Espinosa F, Gómez Rodríguez N, Martín Joven A, Posada García FJ.

Rev Clin Esp. 2001 Apr;201(4):228-9. Spanish. No abstract available.

PMID:
11447919
16.

A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel.

Floyd JS, Kaspera R, Marciante KD, Weiss NS, Heckbert SR, Lumley T, Wiggins KL, Tamraz B, Kwok PY, Totah RA, Psaty BM.

Clin Pharmacol Ther. 2012 May;91(5):896-904. doi: 10.1038/clpt.2011.295. Epub 2012 Mar 14.

17.

Cerivastatin-induced rhabdomyolysis.

Rodríguez ML, Mora C, Navarro JF.

Ann Intern Med. 2000 Apr 4;132(7):598. No abstract available.

PMID:
10744612
18.

Severe rhabdomyolysis related to cerivastatin without gemfibrozil.

Hyman DJ, Henry A, Taylor A.

Ann Intern Med. 2002 Jul 2;137(1):74. No abstract available.

PMID:
12093260
19.

Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis.

Ozaki H, Ishikawa CT, Ishii T, Toyoda A, Murano T, Miyashita Y, Shirai K.

J Clin Pharm Ther. 2005 Apr;30(2):189-92.

PMID:
15811174
20.

Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil.

Alexandridis G, Pappas GA, Elisaf MS.

Am J Med. 2000 Aug 15;109(3):261-2. No abstract available.

PMID:
11023440

Supplemental Content

Support Center